MASSETTI, Anna Paola
 Distribuzione geografica
Continente #
NA - Nord America 3.992
EU - Europa 1.330
AS - Asia 751
SA - Sud America 40
AF - Africa 28
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.151
Nazione #
US - Stati Uniti d'America 3.924
IT - Italia 468
SG - Singapore 251
IN - India 230
SE - Svezia 216
CN - Cina 160
UA - Ucraina 122
FI - Finlandia 120
DE - Germania 99
RO - Romania 80
IE - Irlanda 66
CA - Canada 60
GB - Regno Unito 51
AR - Argentina 32
MY - Malesia 32
TR - Turchia 21
BG - Bulgaria 20
NL - Olanda 17
ID - Indonesia 16
BE - Belgio 13
FR - Francia 11
LU - Lussemburgo 9
TG - Togo 9
RU - Federazione Russa 8
AU - Australia 7
EG - Egitto 7
KR - Corea 7
PH - Filippine 7
AT - Austria 6
JP - Giappone 6
BR - Brasile 5
GE - Georgia 5
GR - Grecia 5
MX - Messico 5
PT - Portogallo 5
BZ - Belize 3
CH - Svizzera 3
ES - Italia 3
IR - Iran 3
PK - Pakistan 3
SA - Arabia Saudita 3
SC - Seychelles 3
CO - Colombia 2
CZ - Repubblica Ceca 2
LY - Libia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
ZA - Sudafrica 2
BD - Bangladesh 1
BJ - Benin 1
CL - Cile 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.151
Città #
Fairfield 570
Chandler 301
Ashburn 287
Woodbridge 270
Houston 248
Seattle 235
Wilmington 228
Dearborn 217
Cambridge 197
Rome 180
Singapore 163
Princeton 132
Ann Arbor 131
Plano 102
San Paolo di Civitate 92
Lawrence 75
Horia 70
Dublin 65
Millbury 65
Beijing 64
Jacksonville 49
San Diego 47
Santa Clara 45
Fremont 38
Boston 37
Ottawa 35
Boardman 32
Federal 31
Milan 30
Helsinki 28
Andover 24
Norwalk 24
Falls Church 23
Sofia 20
Toronto 20
New York 19
Jakarta 16
Munich 15
Nanjing 15
Des Moines 14
Istanbul 14
Brussels 13
Mannheim 12
Bremen 10
London 10
Solbiate Olona 10
Lomé 9
Hefei 8
Kunming 8
Sassoferrato 8
Braunschweig 7
Cairo 7
Guangzhou 7
Nanchang 7
Sydney 7
Dallas 6
Falkenstein 6
Naples 6
Bühl 5
Chicago 5
Durham 5
Jinan 5
Modena 5
Pune 5
Sacramento 5
San Mateo 5
St Petersburg 5
Tbilisi 5
American Fork 4
Amsterdam 4
Ankara 4
Bielefeld 4
Brunn am Gebirge 4
Hebei 4
Iloilo City 4
Phoenix 4
San Jose 4
Shenyang 4
Tappahannock 4
Washington 4
Araraquara 3
Auburn Hills 3
Baltimore 3
Belize City 3
Bern 3
Birmingham 3
Catania 3
Grafing 3
Hoheneggelsen 3
Indiana 3
Jaipur 3
Lahore 3
Latina 3
Lawrenceburg 3
Prato 3
San Francisco 3
Southwark 3
Stendal 3
Thiene 3
Tokyo 3
Totale 4.567
Nome #
The neutrophil/lymphocyte ratio as a prognostic factor in COVID-19 patients: a case-control study 215
Somatization and traumatic events in asylum seekers and refugees resettled in Italy 171
Emergency Department as an epidemiological observatory of Human Mobility. The case of Rome Metropolitan Area (EMAHM). A descriptive analysis of the visits to the ED of the Northern African population 153
A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features 101
"Autoantibodies against ganglioside GM3 represent a portion of antilymphocyte antibodies in AIDS patients”. 99
Emergency Department as an epidemiological observatory of Human Mobility: the experience of the Moroccan population 98
Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series 96
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 90
Diagnostic performance in active TB of QFT-Plus assay and co-expression of CD25/CD134 in response to new antigens of Mycobacterium tuberculosis 89
How are the undocumented migrants in Rome? Assessment of quality of life and its determinants among migrant population 88
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV 87
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 86
Rubella Susceptibility Profile in Pregnant Women with HIV 85
Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline 83
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 82
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. 81
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 80
Successful conservative treatment of peripheral candidal thrombophlebitis: case report. 80
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy. A prospective case-control study 80
The synergistic effect of time of exposure, distance and no use of personal protective equipment in the determination of SARS-CoV-2 infection: Results of a contact tracing follow-up study in healthcareworkers 80
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 79
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 77
Antiretroviral treatment in pregnancy: A six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes 76
Increased carotid intima media thickness is associated with depletion of circulating myeloid dendritic cells in HIV-infected patients on suppressive antiretroviral treatment. 75
Atypical localization of leishmaniasis in an intestinal polyp 73
Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response 73
Adenosine deaminase activity and acquired immunodeficiency syndrome (AIDS). 72
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy 72
Adherence and Genotypic Drug Resistance Mutations in HIV-1-Infected Patients Failing Current Antiretroviral Therapy 72
Plasma lipid profile in pregnant women with HIV receiving nevirapine 72
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells 72
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. 71
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection 71
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 70
Use of Specific Antiretroviral Regimens Among HIV-Infected Women in Italy at Time of Conception: 2001–2011 69
Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy 68
Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection 68
Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy 67
Downregulation of Leukocyte Migration After Treatment With CCR5 Antagonist Maraviroc 67
"Overxpression of monosialoganglioside GM3 on lymphoycte plasma membrane in patients with HIV infection". 66
Chlamydia pneumoniae seroprevalence among HIV-1-infected and uninfected people with known HIV risk factor 65
Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study 64
Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis 64
The role of IL-15 in challenging Acquired Immunodeficiency Syndrome 63
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 63
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: Four years of follow-up 62
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy 61
Rate, correlates and outcomes of repeat pregnancy in HIV-infected women 61
Detection of mycobacterial antigen by dot blot assay in the cerebrospinal fluid of patients with tuberculous meningitis. 58
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease 58
QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis 58
Influence of previous tuberculin skin test on serial IFN-γ release assays 58
Plasmacytoid dendritic cells count in antiretroviral-treated patients is predictive of HIV load control independent of CD4+ T-cell count. 58
Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): A case series from a national study 58
DYSREGULATION OF ADIPOKINES IN HIV-INFECTED PATIENTS UNDER HAART IS A MARKERS FOR CARDIOVASCULAR RISK? 57
Pregnancy outcomes in HIV-infected women of advanced maternal age 57
Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus 57
SWITCHING TO BOOSTED OR UNBOOSTED ATAZANAVIR IMPROVES GLUCOSE TOLERANCE IN HIV INFECTED SUBJECTS: ATAGLU COHORT STUDY 55
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy 55
Deficit severo e persistente delle cellule dendritiche plasmocitoidi nei pazienti con influenza 2009 H1N1 54
MYELIN DEGRADING ACTIVITY IN THE CSF OF HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES 54
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. 54
Factors Influencing Gestational Age-Adjusted Birthweight in a National Series of 600 Newborns from Mothers with HIV 54
“Episodes of transient HIV viraemia (blips) in HIV-multi-experienced patients: the role of adherence” 52
USE OF DOT IMMUNOBINDING ASSAY (DIB) FOR THE RAPID DIAGNOSIS OF HUMAN BRUCELLOSIS 52
Pregnancy Outcomes in Women with Advanced HIV Infection in Italy 52
Invasive aspergillosis in patients with liver disease 52
In vivo and in vitro effects of antituberculosis treatment on mycobacterial Interferon-gamma T cell response. 49
"Cellule dendritiche del sangue periferico nel monitoraggio del paziente con infezione da HIV". 48
Increased Carotid Intima Media Thickness Is Associated with Depletion of Circulating Myeloid Dendritic Cells in Patients on Suppressive ART 46
Interleukin-15 in HIV-infection: immunologic and virologic interactions in antiretroviral-naive and –treated patients. 46
Urolithiasis under atazanavir boosted and tenofovir therapy: a case report.J Chemother. 46
Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy 45
IMMUNOBLOT ANALYSIS OF ANTIBODY-RESPONSE TO SALMONELLA SPP AND ESCHERICHIA-COLI LIPOPOLYSACCHARIDES (LPS) IN TYPHOID PATIENTS 45
In Vivo Release of Alpha-Defensins in Plasma, Neutrophils and CD8 T-Lymphocytes of Patients with HIV Infection 44
"Interferon-g Release Assays (IGRAs) for Detection and Treatment Response of Tuberculosis in Patients with HIV Infection" 43
Candidal thrombophlebitis of central veins: case report and review 43
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report 42
Evaluation of the factors associated with reinfections towards SARS-CoV-2 using a case control design 38
“Ocular syphilis in an HIV-infected patient: active disease or immune reconstitution syndrome?” 37
Tumour Necrosis Factor-alpha Production and Immune Cell Activation in Tuberculous Meningitis. 36
"Utilizzo del TDM nella gestione dei pazienti HIV+ in trattamento ARV" 35
Synergistic effect between SARS-CoV-2 wave and COVID-19 vaccination on the occurrence of mild symptoms in healthcare workers 34
HORMONAL STATUS AND NATURAL IMMUNITY IN HIV INFECTED PATIENTS 34
USE OF DOT IMMUNOBINDING ASSAY FOR THE RAPID DIAGNOSIS OF HUMAN HYDATIDOSIS 34
Interferon-γ release assay in HIV-infected patients with active tuberculosis: impact of antituberculous drugs on host immune response. 34
In vitro effect of HIV protease inhibitors on cytokine production 33
“Impaired adipokine profile in HIV positive patients without metabolic syndrome: the role of antiretroviral therapy.” 33
PHARMACOLOGICAL MODULATION OF APOPTOSIS OF PBMC BY DARUNAVIR AND MARAVIROC 32
“Campagne informative di prevenzione: l’esperienza dell’ANLAIDS Lazio con i ragazzi delle scuole medie superiori”. 32
Neutralizing antibodies against HIV-1 correlated with non progressive course of infection 29
Immunoblot analysis of Salmonella typhi lipopolysaccharide (LPS) using typhoid sera. 29
IMPAIRED ADIPOKINE PROFILE IN HIV POSITIVE PATIENTS: THE ROLE OF BACKBONE 27
Effect in vitro of CCR5 Antagonists on Innate Immune System: Maraviroc Inhibits the Migration of Neutrophils, Macrophages, and DC 27
Elevated levels of tumor necrosis factor (TNF) in the cerebrospinal fluid from patients with HIV-associated neurological disorders. 26
Study of intracellular and immunomodulant effects of CCR5 Antagonist Maraviroc 26
Systemic antibody response to Salmonella typhi lipopolysaccharide in typhoid patients: evaluation by enzyme-linked immunosorbent assay and immunoblotting 25
CSF PROTEOLYTIC ACTIVITY AND MRI-DETECTABLE DEMYELINATION IN HIV-1-INFECTED PATIENTS WITH NEUROLOGICAL DISEASES 24
In vitro downregulation of anti-myelin proteolitic activity by indinavir 23
Principi di Terapia antinfettiva 23
Totale 6.178
Categoria #
all - tutte 18.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.180 0 0 0 0 191 251 226 167 143 93 45 64
2020/2021497 49 78 9 96 7 44 20 46 59 62 21 6
2021/20221.140 2 72 93 32 139 22 37 114 126 83 205 215
2022/20231.215 229 250 56 124 129 116 21 90 96 8 64 32
2023/2024648 45 63 27 34 75 114 16 52 14 69 67 72
2024/2025391 63 79 112 52 85 0 0 0 0 0 0 0
Totale 6.356